
Researchers quietly planned a major test to dim sunlight, records show
But behind the scenes, they were planning a much larger and potentially riskier study of salt water-spraying equipment that could eventually be used to dim the sun's rays — a multimillion-dollar project aimed at producing clouds over a stretch of ocean larger than Puerto Rico.
The details outlined in funding requests, emails, texts and other records obtained by POLITICO's E&E News raise new questions about a secretive billionaire-backed initiative that oversaw last year's brief solar geoengineering experiment on the San Francisco Bay.
They also offer a rare glimpse into the vast scope of research aimed at finding ways to counter the Earth's warming, work that has often occurred outside public view. Such research is drawing increased interest at a time when efforts to address the root cause of climate change — burning fossil fuels — are facing setbacks in the U.S. and Europe. But the notion of human tinkering with the weather and climate has drawn a political backlash and generated conspiracy theories, adding to the challenges of mounting even small-scale tests.
Last year's experiment, led by the University of Washington and intended to run for months, lasted about 20 minutes before being shut down by Alameda city officials who objected that nobody had told them about it beforehand.
That initial test was only meant to be a prequel. Even before it began, the researchers were talking with donors and consultants about conducting a 3,900-square mile cloud-creation test off the west coasts of North America, Chile or south-central Africa, according to more than 400 internal documents obtained by E&E News through an open records request to the University of Washington.
"At such scales, meaningful changes in clouds will be readily detectable from space," said a 2023 research plan from the university's Marine Cloud Brightening Program. The massive experiment would have been contingent upon the successful completion of the thwarted pilot test on the carrier deck in Alameda, according to the plan. The records offer no indication of whether the researchers or their billionaire backers have since abandoned the larger project.
Before the setback in Alameda, the team had received some federal funding and hoped to gain access to government ships and planes, the documents show.
The university and its partners — a solar geoengineering research advocacy group called SilverLining and the scientific nonprofit SRI International — didn't respond to detailed questions about the status of the larger cloud experiment. But SilverLining's executive director, Kelly Wanser, said in an email that the Marine Cloud Brightening Program aimed to "fill gaps in the information" needed to determine if the technologies are safe and effective.
In the initial experiment, the researchers appeared to have disregarded past lessons about building community support for studies related to altering the climate, and instead kept their plans from the public and lawmakers until the testing was underway, some solar geoengineering experts told E&E News. The experts also expressed surprise at the size of the planned second experiment.
"Alameda was a stepping stone to something much larger, and there wasn't any engagement with local communities," said Sikina Jinnah, an environmental studies professor at the University of California in Santa Cruz. "That's a serious misstep."
In response to questions, University of Washington officials downplayed the magnitude of the proposed experiment and its potential to change weather patterns. Instead, they focused on the program's goal of showing that the instruments for making clouds could work in a real-world setting. They also pushed back on critics' assertions that they were operating secretively, noting that team members had previously disclosed the potential for open-ocean testing in scientific papers.
The program does not "recommend, support or develop plans for the use of marine cloud brightening to alter weather or climate," Sarah Doherty, an atmospheric and climate science professor at the university who leads the program, said in a statement to E&E News. She emphasized that the program remains focused on researching the technology, not deploying it. There are no "plans for conducting large-scale studies that would alter weather or climate," she added.
Solar geoengineering encompasses a suite of hypothetical technologies and processes for reducing global warming by reflecting sunlight away from the Earth that are largely unregulated at the federal level. The two most researched approaches include releasing sulfate particles in the stratosphere or spraying saltwater aerosols over the ocean.
But critics of the technologies warn that they could also disrupt weather patterns — potentially affecting farm yields, wildlife and people. Even if they succeed in cooling the climate, temperatures could spike upward if the processes are abruptly shut down before countries have transitioned away from burning planet-warming fossil fuels, an outcome described by experts as 'termination shock.'
As a result, even researching them is controversial — and conspiracy theories driven by weather tragedies have worsened the backlash.
Rep. Marjorie Taylor Greene (R-Ga.) has erroneously suggested that geoengineering is responsible for the deadly July 4 flood in Texas and introduced a bill to criminalize the technology. Retired Lt. Gen. Mike Flynn, a former national security adviser to President Donald Trump, has embraced similar untruths.
Meanwhile, more than 575 scientists have called for a ban on geoengineering development because it "cannot be governed globally in a fair, inclusive, and effective manner." And in Florida, Republican Gov. Ron DeSantis signed a law last month that bans the injection or release of chemicals into the atmosphere 'for the express purpose of affecting the temperature, weather, climate, or intensity of sunlight.'
Conspiracy theories involving the weather have reached enough of a pitch that EPA Administrator Lee Zeldin released a tranche of information this month debunking the decades-old claim that jet planes intentionally release dangerous chemicals in their exhaust to alter the weather or control people's minds.
The small Alameda experiment was one of several outdoor solar geoengineering studies that have been halted in recent years due to concerns that organizers had failed to consult with local communities. The city council voted to block the sprayer test in June 2024 after Mayor Marilyn Ezzy Ashcraft, a Democrat, complained that she had first learned about it by reading a New York Times article.
The Alameda officials' sharp reaction echoed responses to past blunders by other geoengineering researchers. An experiment in Sweden's Arctic region that sought to release reflective particles in the stratosphere was canceled in 2021 after Indigenous people and environmentalists accused Harvard University of sidelining them. The entire program, known as SCoPEx, was terminated last year.
"It's absolutely imperative to engage with both local communities and broader publics around not just the work that is being proposed or is being planned, but also the broader implications of that work," said Jinnah, the UC Santa Cruz professor, who served on the advisory board for SCoPEx.
That view isn't universally shared in the solar geoengineering research community. Some scientists believe that the perils of climate change are too dire to not pursue the technology, which they say can be safely tested in well-designed experiments, such as the one in Alameda.
"If we really were serious about the idea that to do any controversial topic needs some kind of large-scale consensus before we can research the topic, I think that means we don't research topics," David Keith, a geophysical sciences professor at the University of Chicago, said at a think tank discussion last month. Keith previously helped lead the canceled Harvard experiment.
The trove of documents shows that officials with the Marine Cloud Brightening Program were in contact with officials from the National Oceanic and Atmospheric Administration and the consulting firm Accenture as the researchers prepared for the much larger ocean test — even before the small field test had begun on the retired aircraft carrier USS Hornet. They had hoped to gain access to U.S. government ships, planes and research funding for the major experiment at sea. (NOAA did not respond to a request for comment.)
After local backlash doomed the Alameda test, the team acknowledged that those federal resources were likely out of reach. The prospect of U.S. backing became more distant with the reelection of Trump, who opposes federal support for measures to limit global warming. (The White House didn't respond to a request for comment.)
The program's donors include cryptocurrency billionaire Chris Larsen, the philanthropist Rachel Pritzker and Chris Sacca, a venture capitalist who has appeared on Shark Tank and other TV shows. (Pritzker and Sacca didn't respond to requests for comment.)
Larsen said research of marine cloud brightening is needed due to questions about the effectiveness and impacts of the technology. "At a time when scientists are facing political attacks and drastic funding cuts, we need to complement a rapid energy transition with more research into a broad range of potential climate solutions," he wrote in an email to E&E News.
The 2023 research plan shows that the experiments in Alameda and at sea would have cost between $10 million and $20 million, with "large uncertainties" due to operational or government funding challenges and the potential to expand the "field studies to multiple geographic locations."
They would require "significant cash at the outset" and continued support over several years, the plan said. It was submitted as part of a funding request to the Quadrature Climate Foundation, a charity associated with the London-based hedge fund Quadrature Capital.
The Quadrature foundation told E&E News it had given nearly $11.9 million to SilverLining and $5 million to the University of Washington for research on solar geoengineering, which is also known as solar radiation management, or SRM.
"Public and philanthropic institutions have a role in developing the knowledge needed to assess approaches like SRM," Greg De Temmerman, the foundation's chief science officer, said in a statement. The goal is to ensure that decisions about the potential use of the technologies "are made responsibly, transparently, and in the public interest."
For more than a dozen years, the University of Washington has been studying marine cloud brightening to see if the potential cooling effects are worth the risks, the research team told Quadrature.
"The MCB Program was formed in 2012 and operated as a largely unfunded collaboration until 2019, when modest philanthropic funding supported the commencement of dedicated effort," the plan said.
The source of the program's initial financial support isn't named in the document. But the timing coincides with the establishment of SilverLining, which is six years old.
SilverLining reported more than $3.6 million in revenues in 2023, the most recent year for which its tax filings are publicly available. The group does not disclose its full list of donors, although charities linked to former Democratic New York Gov. Eliot Spitzer and the late Gordon Moore, a co-founder of the chipmaker Intel, have reported six-figure contributions to the group. (The Bernard and Anne Spitzer Charitable Trust didn't respond to a request for comment.)
'The Moore Foundation is not involved in the Marine Cloud Brightening Program," said Holly Potter, a spokesperson for the charity, adding that 'solar geoengineering research in not a focus of the foundation's work.'
The program pitched Quadrature and other donors on the idea that its need for private philanthropy was only temporary. Public support would eventually arrive for solar geoengineering research, the team argued.
In a 2021 update for supporters, the team said it had received $1 million over two years from NOAA and the Department of Energy for modeling studies and had begun work on the modified snow-making machine that the researchers would later test in Alameda. That technology is also being used in a field trial along the Great Barrier Reef that's funded in part by the Australian government.
At the same time, the donor report acknowledged the potential for "public perception challenges" like those that would later short-circuit the Alameda field test. "The MCB Program is well-positioned both in terms of its government ties, scientific analogues and careful positioning to move forward successfully, but this remains a risk."
The plan for Alameda included elements to engage the public. The deck of the USS Hornet, which is now a naval museum, remained open to visitors.
But the team relied on museum staff to manage relations with Alameda leaders and carefully controlled the information it provided to the public, according to the documents provided by the University of Washington that included communications among the program leaders.
"We think it's safest to get air quality review help and are pursuing that in advance of engaging, but I'd avoid scaring them overly," said an Aug. 23, 2023, text message before a meeting with Hornet officials. "We want them to work largely on the assumption that things are a go." No names were attached to the messages.
Then in November 2023, a climate solutions reporter from National Public Radio was planning to visit the headquarters of SRI for a story about the importance of aerosols research. A communications strategist who worked for SilverLining at the time emailed the team a clear directive: "There will be no mention of the study taking place in Alameda," wrote Jesus Chavez, the founder of the public relations firm Singularity Media, in bold, underlined text. (Chavez didn't respond to a request for comment.)
At the same time, the program was closely coordinating with government scientists, documents show.
The head of NOAA's chemical sciences division was one of three "VIPs' who were scheduled to visit the headquarters of SRI for a demonstration of a cloud-making machine, according to a December 2023 email from Wanser of SilverLining. Other guests included a dean from the University of Washington and an official from the private investment office of billionaire philanthropist Bill Gates, a long-time supporter of geoengineering research. (Gates Ventures didn't respond to a request for comment.)
'The focus of this event is on the spray technology and the science driving its requirements, validation and possible uses,' Wanser wrote to the team.
The same month, the program detailed its progress toward the Alameda experiment in another donor report.
'The science plan for the study has been shared with our colleagues at NOAA and DOE,' said a draft of the report.
A Department of Energy spokesperson acknowledged funding University of Washington 'research on how ambient aerosols affect clouds,' but said the agency hadn't supported "deliberate field deployment of aerosols into the environment.'
On April 1, 2024, the day before the Alameda experiment was launched, the program and its consultants appeared to be laying the groundwork for additional geoengineering tests, which an adviser said would likely need the support of federal officials.
Leaders from SilverLining, SRI and Accenture were invited to attend the discussion 'to kick off the next phase of our work together' in the consulting firm's 33rd floor offices in Salesforce Tower, the tallest building in San Francisco, a calendar invitation shows. Officials from the University of Washington and NOAA were also given the option to join. That evening, the calendar notifications show, everyone was invited to a happy hour and dinner.
Accenture, SRI, the University of Washington and NOAA didn't directly respond to questions about the events. Wanser of SilverLining said in an email that the San Francisco meeting "was completely separate" from the cloud brightening program, even though it included many of the same researchers.
The following afternoon, team members and Accenture executives planned to give a sprayer demonstration to Pritzker, an heir to the Hyatt Hotels fortune and board chair of the think tanks Third Way and the Breakthrough Institute, and Michael Brune, a former executive director of the Sierra Club, according to another scheduling document.
It was an important moment for the team. The same technology that was being tested on the aircraft carrier's deck would also be deployed in the much larger open-ocean experiment, the research plan shows.
"I was impressed with the team that was putting it together," Brune said in an interview. He attended the demo as an adviser to Larson, the crypto entrepreneur who has donated to SilverLining via the Silicon Valley Community Foundation.
Brune, who lives in Alameda, said he wasn't aware of the larger experiment until E&E News contacted him. "The engagement with leaders here in Alameda was subpar, and the controversy was pretty predictable," he added.
In May 2024, city officials halted the experiment after complaining about the secrecy surrounding it. They also accused the organizers of violating the Hornet's lease, which was only intended to allow museum-related activities. (The Hornet didn't respond to a request for comment.)
At a city council meeting the following month, Mayor Ashcraft said she wanted "a deeper understanding of the unintended consequences … not just of this small-scale experiment, but of the science, of this technology [and] where it's leading to." Then she and the other four council members voted unanimously to block the program from resuming its experiment.
Between April 2024 and the city council's vote that June, the research team scrambled to limit public backlash against the test. By then, the controversy had attracted national and local media attention.
The information request from E&E News sought roughly 14 months of text messages from or to Doherty and Robert Wood, another University of Washington researcher, that included or mentioned their collaborators at SilverLining or SRI. Some of the text messages that were shared by the university did not specify the sender, and Doherty and Wood did not respond to questions about them.
In one text message chain on May 15, 2024, one person suggested SilverLining would pay to keep the Hornet museum closed when the tests were running "to give us some breathing space."
The sender added, "for risk management and the project [it's] an easy call, and we can cover it."
But an unidentified second person responded that "the community could actually find it additionally problematic that the project kept the Hornet shut down."
The team members sent each other letters from people who supported the program, including one from science fiction writer Kim Stanley Robinson, whose 2020 novel Ministry of the Future featured a rogue nation that unilaterally implemented planetary-scale solar geoengineering.
"The truth is that in the coming decades we are going to have to cope with climate change in many ways involving both technologies and social decisions," he wrote to the city council on May 29, 2024. The Alameda experiment "has the advantage of exploring a mitigation method that is potentially very significant, while also being localized, modular, and reversible. These are qualities that aren't often attributed to geoengineering."
After the council vote, SilverLining hired a new public relations firm, Berlin Rosen, to handle the media attention. It also discussed organizing local events to recruit potential allies, emails show.
Wanser, SilverLining's executive director, wrote in a June 6, 2024, email to the research team that the program was considering "another run at a proposal to the city post-election, with, hopefully, a build up of local support and education in the interim."
Ashcraft, the mayor, said in an email to E&E News that she is "not aware of any additional outreach with the community" by the researchers, adding that they hadn't engaged with her or city staff since the vote.
Meanwhile, even before Trump returned to office, the team had begun acknowledging that its mistakes in Alameda had decreased the likelihood of gaining government support for solar geoengineering research. Access to federal aircraft "isn't going to happen any time soon," Doherty, the program director, wrote to Wanser and other team members on June 14, 2024.
The studies that the program is pursuing are scientifically sound and would be unlikely to alter weather patterns — even for the Puerto Rico-sized test, said Daniele Visioni, a professor of atmospheric sciences at Cornell University. Nearly 30 percent of the planet is already covered by clouds, he noted.
That doesn't mean the team was wise to closely guard its plans, said Visioni, who last year helped author ethical guidelines for solar geoengineering research.
"There's a difference between what they should have been required to do and what it would have been smart for them to do, from a transparent perspective, to gain the public's trust," he said.
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Genentech and Roche Present New Insights in Alzheimer's Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
– Trontinemab's Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% becoming amyloid PET negative and ARIA-E remaining <5% – – Design of the Phase III TRONTIER 1 and 2 studies of trontinemab in early symptomatic Alzheimer's disease featured, with initiation planned in 2025 – – Plans for new Phase III trial investigating trontinemab in preclinical Alzheimer's disease, in people at high risk of cognitive decline – – New real-world data support Elecsys pTau217 as a standalone blood test, comparable to a PET scan, for rule-in and rule-out identification of amyloid pathology – SOUTH SAN FRANCISCO, Calif., July 28, 2025--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer's development portfolio is being presented at the Alzheimer's Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data exemplify the comprehensive approach Roche is taking in addressing Alzheimer's across the entire patient journey. Featured oral presentations include the latest results from the ongoing Phase Ib/IIa Brainshuttle™ AD study, which continue to support rapid and robust reduction of amyloid plaques, and design of the Phase III TRONTIER 1 and 2 studies of investigational trontinemab for early symptomatic Alzheimer's disease, with initiation planned later this year. As part of its growing Alzheimer's development program, Roche announced today its plans for an additional Phase III trial to investigate trontinemab in preclinical Alzheimer's disease. The trial will focus on individuals at risk of cognitive decline, with the goal of potentially delaying or preventing the progression of the disease to symptomatic stages. "Alzheimer's disease represents one of the greatest challenges in healthcare today and tackling it requires early detection and effective therapeutics," said Levi Garraway, M.D., Ph.D., chief medical officer and head of Global Product Development. "Trontinemab is designed to target a key driver of Alzheimer's disease biology more effectively in the brain. Combining new treatment avenues with advanced diagnostics may enable earlier and potentially more effective intervention. With plans for Phase III trials in both early symptomatic and preclinical Alzheimer's disease, we are advancing science with the goal of delaying—and ultimately preventing—progression of this devastating condition." Late-breaking oral and poster presentations highlight the potential of Roche's Elecsys® pTau217 as a reliable and accessible blood-based biomarker test, providing comparable results to PET scan and cerebrospinal fluid (CSF) diagnostics for rule-in and rule-out diagnosis of amyloid pathology, a hallmark of Alzheimer's disease, across care settings. The test, which received Breakthrough Device Designation from the U.S. Food and Drug Administration last year, will also be utilized in Roche's TRONTIER studies. "Blood based testing for Alzheimer's disease has the potential to greatly improve patient access and decrease the time to definitive disease diagnosis," said Matt Sause, CEO of Roche Diagnostics. "Our data show that the Elecsys pTau217 test performs comparably to PET scans but can be performed with a simple blood draw and analyzed in a routine clinical laboratory. This has the potential to transform the diagnosis of Alzheimer's and provide clear answers to caregivers, patients, and their families." Up to 75% of people living with symptoms of Alzheimer's disease globally have not been diagnosed, and those who have, waited an average of 2.8 years, and even less have received any form of treatment. Diagnostics play a crucial role in addressing the global challenge of Alzheimer's, not only to detect and identify people with the disease early, even before the first symptoms, but also to rule out those who may or may not benefit from specific treatments. Pharmaceuticals In a 90-minute Featured Research session, designs were shared for the Phase III studies, TRONTIER 1 and 2, which will initiate later this year, investigating the efficacy and safety of investigational trontinemab in people with early Alzheimer's disease. The primary endpoint will measure the change in cognition and function based on the Clinical Dementia Rating – Sum of Boxes scale after 18 months of treatment. Secondary endpoints will include assessments of cognition, function, behavioral symptoms, and quality of life. A pre-screening study, TRAVELLER, based on a brief clinical assessment and a plasma biomarker, which will be identified using the Elecsys pTau217 test, has also been initiated, to enable broader community outreach and extend access to these trials to more diverse populations representative of Alzheimer's disease. New data on the latest results for trontinemab from the completed dose-expansion part of the 1.8 mg/kg and 3.6 mg/kg cohorts from the ongoing Phase Ib/IIa Brainshuttle AD study continued to show rapid and robust reduction of amyloid plaques in the brain as measured by amyloid positron emission tomography (PET). In the 3.6 mg/kg cohort, trontinemab reduced amyloid levels below the 24 centiloid positivity threshold in 91% of participants (n=49/54) after 28 weeks of treatment; 72% (n=39/54) achieved deep clearance below 11 centiloids. These data were reinforced by early and significant reductions in fluid biomarkers of Alzheimer's disease, including total tau, phosphorylated Tau (pTau)181, pTau217, and neurogranin measured in CSF and continues to show a favourable safety and tolerability profile. Amyloid-related imaging abnormalities-edema/effusion (ARIA-E) continued to be observed in <5% of participants (blinded data; N=4/149 across 1.8 and 3.6 mg/kg dose cohorts). All cases were radiographically mild, one was associated with mild and transient symptoms. Diagnostics Roche will present data on a new study comparing the pTau217/Ab42 plasma ratio to the high-throughput, fully automated Elecsys pTau217 assay. The presentation will report on the accuracy of these tools in detecting amyloid pathology. Together with the high throughput and full automation of the assay, these data will assess the potential of Elecsys pTau217 as an accurate standalone rule-in and rule-out test that could be scaled up for broad implementation in routine clinical practice worldwide. Additionally, results from a cohort-based model of healthcare utilization in the U.S. demonstrated that using the Elecsys® pTau181 blood-based rule-out test in primary care scenarios improved diagnostic accuracy and reduced resource use compared with the current standard-of-care clinical, cognitive and imaging tests. If made available in primary care settings, the Roche Elecsys® pTau181 blood test has the potential to reliably avoid the need for further confirmatory testing in nearly all people who receive a negative result. This will avoid the need for these people to undergo unnecessary testing using CSF or PET, which often come with long wait times and high cost, resulting in further delays to diagnosis and cost to healthcare systems. Medicine Abstract title Presentation number (type) Presentation date (session) Time Abstracts will be available on the AAIC website. Pharmaceuticals Next wave of innovation in Alzheimer's disease therapeutics: The value of novel active transport mechanisms Featured Research Session (FRS), Talk 1 Room 718 27 July 2025, 2pm - 3:30pm EDT Cath Mummery, Roberto Villaseñor, Jens Niewoehner, Scarlett Barker, Luka Kulic Latest results from the dose-expansion part (Part 2) of the Brainshuttle™ AD study of trontinemab in people with Alzheimer's disease Featured Research Session (FRS), Talk 2 Room 718 27 July 2025, 2pm - 3:30pm EDT Luka Kulic, Fabien Alcaraz, Gregory Klein, Stephen Salloway, Carsten Hofmann, João A. Abrantes, Stella Yilmaz, Denise Sickert, Maddalena Marchesi, Jakub Wojtowicz, Andres Schneider, Ruth Croney, David Agnew, Silke Ahlers, Paul Delmar, Hanno Svoboda, Iris Wiesel Interim biomarker results for trontinemab, a novel Brainshuttle™ antibody in development for the treatment of Alzheimer's disease Featured Research Session (FRS), Talk 3 Room 718 27 July 2025, 2pm - 3:30pm EDT Gregory Klein, Gil Rabinovici, Henrik Zetterberg, Matteo Tonietto, Tobias Bittner, Daria Rukina, Fabien Alcaraz, Carsten Hofmann, Maddalena Marchesi, Jakub Wojtowicz, Ruth Croney, David Agnew, João A. Abrantes, Franziska Schaedeli Stark, Silke Ahlers, Paul Delmar, Hanno Svoboda, Iris Wiesel, Luka Kulic TRONTIER 1 and TRONTIER 2: Pivotal trials of trontinemab in early symptomatic Alzheimer's disease Featured Research Session (FRS), Talk 4 Room 718 27 July 2025, 2pm - 3:30pm EDT Janice Smith, Catherine Mummery, Jeffrey L. Cummings, Gil Rabinovici, Stephen Salloway, Reisa Sperling, Henrik Zetterberg, Angeliki Thanasopolou, Christopher Lane, Paul Delmar, Gregory Klein, Ruth Croney, Jakub Wojtowicz, Carsten Hofmann, Luka Kulic, Hideki Garren Diagnostics Evaluating the Impact on Diagnostic Performance and Healthcare Resource Utilization of Introducing a plasma rule-out test in the Alzheimer's Disease Diagnostic Pathway Poster #102729 27 July 2025, 7:30am - 4:15pm EDT Sophie Roth, Gustaf Ortsäter, Joana Amorim Freire Location tbc Evaluating the Clinical Performance of the Elecsys pTau217 Plasma Immunoassay to Detect Amyloid Pathology in a Routine Clinical Practice Cohort Poster #96679 28 July 2025, 7:30am – 4:15pm EDT Sayuri Hortsch, Niels Borlinghaus, Alexander Jethwa, David Caley, Annunziata Di Domenico, Craig Ritchie Clinical performance and effect of pre-analytical variation of plasma pTau217 alone versus the plasma pTau217/Aβ42 ratio for the identification of amyloid pathology Oral Developing Topics #108585 3-23-DEV Developing Topics on Tau Biomarkers 29 July 2025, 2:00pm – 3:30pm EDT Christopher M. Rank, Joana Amorim Freire, Alexander Jethwa, Annunziata Di Domenico, Christina Rabe, Marc Suárez-Calvet, Colin L. Masters, Tobias Bittner Accuracy of cerebrospinal fluid biomarker ratios to determine amyloid positron-emission tomography status: a diagnostic test accuracy meta-analysis Poster #100941 28 July 2025, 7:30am – 4:15pm EDT Pablo Martinez-Lage, Eino Solje, Julian G. Martins, Sraboni Sarkar Equity in diagnosis through adequate clinical trial design in diagnostic performance studies Poster #102804 30 July 2025, 7:30am - 4:15pm EDT Imke Kirste, David Caley, Clara Quijano Rubio, Margherita Carboni Investigating Differences in Patients Enrolled in a Clinical Study Based on Referral Type Poster #108110 30 July 2025, 7:30am - 4:15pm EDT Sophie Roth, Laura Schlieker, Sayuri Hortsch, Joana Amorim Freire, David Caley About trontinemab Trontinemab is an investigational Brainshuttle bispecific 2+1 amyloid-beta targeting monoclonal antibody specifically engineered for enhanced access to the brain to enable rapid reduction of amyloid in people with Alzheimer's disease. Trontinemab is designed for the efficient transport across the blood-brain barrier to target aggregated forms of amyloid beta and remove amyloid plaques in the brain. The uniqueness of trontinemab is based on Roche's proprietary Brainshuttle technology combining an amyloid beta-binding antibody with a transferring receptor (TfR1) shuttle module. As a result, high central nervous system (CNS) exposure of trontinemab may be achieved at low doses, leading to a rapid and deep amyloid clearance. Due to its unique properties, trontinemab might unlock the full potential of disease-modifying monoclonal antibodies by effectively penetrating the brain and potentially leading to slowing of disease progression. About Roche in Alzheimer's Disease With more than two decades of scientific research in Alzheimer's disease, Roche is working towards a day when we can detect and treat the disease early, in order to slow down, stop or even prevent its progression to preserve what makes people who they are. Today, the company's Alzheimer's disease portfolio spans investigational medicines for different targets, types and stages of the disease, including trontinemab. On the diagnostics side, it also includes approved and investigational tools, including digital and blood-based tests and CSF assays, aiming to more effectively detect, diagnose and monitor the disease. Yet the global challenges of Alzheimer's disease go well beyond the capabilities of science, and making a meaningful impact requires collaboration both within the Alzheimer's community and outside of healthcare. Roche will continue to work together with numerous partners with the hope to transform millions of lives. About Genentech in Neuroscience Neuroscience is a major focus of research and development at Genentech. Our goal is to pursue groundbreaking science to develop new treatments that help improve the lives of people with chronic and potentially devastating diseases. Genentech and Roche are investigating more than a dozen medicines for neurological disorders, including multiple sclerosis, spinal muscular atrophy, neuromyelitis optica spectrum disorder, Alzheimer's disease, Huntington's disease, Parkinson's disease and Duchenne muscular dystrophy. Together with our partners, we are committed to pushing the boundaries of scientific understanding to solve some of the most difficult challenges in neuroscience today. About Genentech Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit View source version on Contacts Media Contact: Meghan Hindman (650) 467-6800Advocacy Contact: Jenee Williams (650) 303-2958Investor Contacts: Loren Kalm (650) 225-3217Bruno Eschli +41616875284 Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
8 hours ago
- Yahoo
Researchers quietly planned a test to dim sunlight. They wanted to ‘avoid scaring' the public.
A team of researchers in California drew notoriety last year with an aborted experiment on a retired aircraft carrier that sought to test a machine for creating clouds. But behind the scenes, they were planning a much larger and potentially riskier study of salt water-spraying equipment that could eventually be used to dim the sun's rays — a multimillion-dollar project aimed at producing clouds over a stretch of ocean larger than Puerto Rico. The details outlined in funding requests, emails, texts and other records obtained by POLITICO's E&E News raise new questions about a secretive billionaire-backed initiative that oversaw last year's brief solar geoengineering experiment on the San Francisco Bay. They also offer a rare glimpse into the vast scope of research aimed at finding ways to counter the Earth's warming, work that has often occurred outside public view. Such research is drawing increased interest at a time when efforts to address the root cause of climate change — burning fossil fuels — are facing setbacks in the U.S. and Europe. But the notion of human tinkering with the weather and climate has drawn a political backlash and generated conspiracy theories, adding to the challenges of mounting even small-scale tests. Last year's experiment, led by the University of Washington and intended to run for months, lasted about 20 minutes before being shut down by Alameda city officials who objected that nobody had told them about it beforehand. That initial test was only meant to be a prequel. Even before it began, the researchers were talking with donors and consultants about conducting a 3,900-square mile cloud-creation test off the west coasts of North America, Chile or south-central Africa, according to more than 400 internal documents obtained by E&E News through an open records request to the University of Washington. "At such scales, meaningful changes in clouds will be readily detectable from space," said a 2023 research plan from the university's Marine Cloud Brightening Program. The massive experiment would have been contingent upon the successful completion of the thwarted pilot test on the carrier deck in Alameda, according to the plan. The records offer no indication of whether the researchers or their billionaire backers have since abandoned the larger project. Before the setback in Alameda, the team had received some federal funding and hoped to gain access to government ships and planes, the documents show. The university and its partners — a solar geoengineering research advocacy group called SilverLining and the scientific nonprofit SRI International — didn't respond to detailed questions about the status of the larger cloud experiment. But SilverLining's executive director, Kelly Wanser, said in an email that the Marine Cloud Brightening Program aimed to "fill gaps in the information" needed to determine if the technologies are safe and effective. In the initial experiment, the researchers appeared to have disregarded past lessons about building community support for studies related to altering the climate, and instead kept their plans from the public and lawmakers until the testing was underway, some solar geoengineering experts told E&E News. The experts also expressed surprise at the size of the planned second experiment. "Alameda was a stepping stone to something much larger, and there wasn't any engagement with local communities," said Sikina Jinnah, an environmental studies professor at the University of California in Santa Cruz. "That's a serious misstep." In response to questions, University of Washington officials downplayed the magnitude of the proposed experiment and its potential to change weather patterns. Instead, they focused on the program's goal of showing that the instruments for making clouds could work in a real-world setting. They also pushed back on critics' assertions that they were operating secretively, noting that team members had previously disclosed the potential for open-ocean testing in scientific papers. The program does not "recommend, support or develop plans for the use of marine cloud brightening to alter weather or climate," Sarah Doherty, an atmospheric and climate science professor at the university who leads the program, said in a statement to E&E News. She emphasized that the program remains focused on researching the technology, not deploying it. There are no "plans for conducting large-scale studies that would alter weather or climate," she added. Solar geoengineering encompasses a suite of hypothetical technologies and processes for reducing global warming by reflecting sunlight away from the Earth that are largely unregulated at the federal level. The two most researched approaches include releasing sulfate particles in the stratosphere or spraying saltwater aerosols over the ocean. But critics of the technologies warn that they could also disrupt weather patterns — potentially affecting farm yields, wildlife and people. Even if they succeed in cooling the climate, temperatures could spike upward if the processes are abruptly shut down before countries have transitioned away from burning planet-warming fossil fuels, an outcome described by experts as 'termination shock.' As a result, even researching them is controversial — and conspiracy theories driven by weather tragedies have worsened the backlash. Rep. Marjorie Taylor Greene (R-Ga.) has erroneously suggested that geoengineering is responsible for the deadly July 4 flood in Texas and introduced a bill to criminalize the technology. Retired Lt. Gen. Mike Flynn, a former national security adviser to President Donald Trump, has embraced similar untruths. Meanwhile, more than 575 scientists have called for a ban on geoengineering development because it "cannot be governed globally in a fair, inclusive, and effective manner." And in Florida, Republican Gov. Ron DeSantis signed a law last month that bans the injection or release of chemicals into the atmosphere 'for the express purpose of affecting the temperature, weather, climate, or intensity of sunlight.' Conspiracy theories involving the weather have reached enough of a pitch that EPA Administrator Lee Zeldin released a tranche of information this month debunking the decades-old claim that jet planes intentionally release dangerous chemicals in their exhaust to alter the weather or control people's minds. The small Alameda experiment was one of several outdoor solar geoengineering studies that have been halted in recent years due to concerns that organizers had failed to consult with local communities. The city council voted to block the sprayer test in June 2024 after Mayor Marilyn Ezzy Ashcraft, a Democrat, complained that she had first learned about it by reading a New York Times article. The Alameda officials' sharp reaction echoed responses to past blunders by other geoengineering researchers. An experiment in Sweden's Arctic region that sought to release reflective particles in the stratosphere was canceled in 2021 after Indigenous people and environmentalists accused Harvard University of sidelining them. The entire program, known as SCoPEx, was terminated last year. "It's absolutely imperative to engage with both local communities and broader publics around not just the work that is being proposed or is being planned, but also the broader implications of that work," said Jinnah, the UC Santa Cruz professor, who served on the advisory board for SCoPEx. That view isn't universally shared in the solar geoengineering research community. Some scientists believe that the perils of climate change are too dire to not pursue the technology, which they say can be safely tested in well-designed experiments, such as the one in Alameda. "If we really were serious about the idea that to do any controversial topic needs some kind of large-scale consensus before we can research the topic, I think that means we don't research topics," David Keith, a geophysical sciences professor at the University of Chicago, said at a think tank discussion last month. Keith previously helped lead the canceled Harvard experiment. The trove of documents shows that officials with the Marine Cloud Brightening Program were in contact with officials from the National Oceanic and Atmospheric Administration and the consulting firm Accenture as the researchers prepared for the much larger ocean test — even before the small field test had begun on the retired aircraft carrier USS Hornet. They had hoped to gain access to U.S. government ships, planes and research funding for the major experiment at sea. (NOAA did not respond to a request for comment.) After local backlash doomed the Alameda test, the team acknowledged that those federal resources were likely out of reach. The prospect of U.S. backing became more distant with the reelection of Trump, who opposes federal support for measures to limit global warming. (The White House didn't respond to a request for comment.) The program's donors include cryptocurrency billionaire Chris Larsen, the philanthropist Rachel Pritzker and Chris Sacca, a venture capitalist who has appeared on Shark Tank and other TV shows. (Pritzker and Sacca didn't respond to requests for comment.) Larsen said research of marine cloud brightening is needed due to questions about the effectiveness and impacts of the technology. "At a time when scientists are facing political attacks and drastic funding cuts, we need to complement a rapid energy transition with more research into a broad range of potential climate solutions," he wrote in an email to E&E News. The 2023 research plan shows that the experiments in Alameda and at sea would have cost between $10 million and $20 million, with "large uncertainties" due to operational or government funding challenges and the potential to expand the "field studies to multiple geographic locations." They would require "significant cash at the outset" and continued support over several years, the plan said. It was submitted as part of a funding request to the Quadrature Climate Foundation, a charity associated with the London-based hedge fund Quadrature Capital. The Quadrature foundation told E&E News it had given nearly $11.9 million to SilverLining and $5 million to the University of Washington for research on solar geoengineering, which is also known as solar radiation management, or SRM. "Public and philanthropic institutions have a role in developing the knowledge needed to assess approaches like SRM," Greg De Temmerman, the foundation's chief science officer, said in a statement. The goal is to ensure that decisions about the potential use of the technologies "are made responsibly, transparently, and in the public interest." For more than a dozen years, the University of Washington has been studying marine cloud brightening to see if the potential cooling effects are worth the risks, the research team told Quadrature. "The MCB Program was formed in 2012 and operated as a largely unfunded collaboration until 2019, when modest philanthropic funding supported the commencement of dedicated effort," the plan said. The source of the program's initial financial support isn't named in the document. But the timing coincides with the establishment of SilverLining, which is six years old. SilverLining reported more than $3.6 million in revenues in 2023, the most recent year for which its tax filings are publicly available. The group does not disclose its full list of donors, although charities linked to former Democratic New York Gov. Eliot Spitzer and the late Gordon Moore, a co-founder of the chipmaker Intel, have reported six-figure contributions to the group. (The Bernard and Anne Spitzer Charitable Trust didn't respond to a request for comment.) 'The Moore Foundation is not involved in the Marine Cloud Brightening Program," said Holly Potter, a spokesperson for the charity, adding that 'solar geoengineering research in not a focus of the foundation's work.' The program pitched Quadrature and other donors on the idea that its need for private philanthropy was only temporary. Public support would eventually arrive for solar geoengineering research, the team argued. In a 2021 update for supporters, the team said it had received $1 million over two years from NOAA and the Department of Energy for modeling studies and had begun work on the modified snow-making machine that the researchers would later test in Alameda. That technology is also being used in a field trial along the Great Barrier Reef that's funded in part by the Australian government. At the same time, the donor report acknowledged the potential for "public perception challenges" like those that would later short-circuit the Alameda field test. "The MCB Program is well-positioned both in terms of its government ties, scientific analogues and careful positioning to move forward successfully, but this remains a risk." The plan for Alameda included elements to engage the public. The deck of the USS Hornet, which is now a naval museum, remained open to visitors. But the team relied on museum staff to manage relations with Alameda leaders and carefully controlled the information it provided to the public, according to the documents provided by the University of Washington that included communications among the program leaders. "We think it's safest to get air quality review help and are pursuing that in advance of engaging, but I'd avoid scaring them overly," said an Aug. 23, 2023, text message before a meeting with Hornet officials. "We want them to work largely on the assumption that things are a go." No names were attached to the messages. Then in November 2023, a climate solutions reporter from National Public Radio was planning to visit the headquarters of SRI for a story about the importance of aerosols research. A communications strategist who worked for SilverLining at the time emailed the team a clear directive: "There will be no mention of the study taking place in Alameda," wrote Jesus Chavez, the founder of the public relations firm Singularity Media, in bold, underlined text. (Chavez didn't respond to a request for comment.) At the same time, the program was closely coordinating with government scientists, documents show. The head of NOAA's chemical sciences division was one of three "VIPs' who were scheduled to visit the headquarters of SRI for a demonstration of a cloud-making machine, according to a December 2023 email from Wanser of SilverLining. Other guests included a dean from the University of Washington and an official from the private investment office of billionaire philanthropist Bill Gates, a long-time supporter of geoengineering research. (Gates Ventures didn't respond to a request for comment.) 'The focus of this event is on the spray technology and the science driving its requirements, validation and possible uses,' Wanser wrote to the team. The same month, the program detailed its progress toward the Alameda experiment in another donor report. 'The science plan for the study has been shared with our colleagues at NOAA and DOE,' said a draft of the report. A Department of Energy spokesperson acknowledged funding University of Washington 'research on how ambient aerosols affect clouds,' but said the agency hadn't supported "deliberate field deployment of aerosols into the environment.' On April 1, 2024, the day before the Alameda experiment was launched, the program and its consultants appeared to be laying the groundwork for additional geoengineering tests, which an adviser said would likely need the support of federal officials. Leaders from SilverLining, SRI and Accenture were invited to attend the discussion 'to kick off the next phase of our work together' in the consulting firm's 33rd floor offices in Salesforce Tower, the tallest building in San Francisco, a calendar invitation shows. Officials from the University of Washington and NOAA were also given the option to join. That evening, the calendar notifications show, everyone was invited to a happy hour and dinner. Accenture, SRI, the University of Washington and NOAA didn't directly respond to questions about the events. Wanser of SilverLining said in an email that the San Francisco meeting "was completely separate" from the cloud brightening program, even though it included many of the same researchers. The following afternoon, team members and Accenture executives planned to give a sprayer demonstration to Pritzker, an heir to the Hyatt Hotels fortune and board chair of the think tanks Third Way and the Breakthrough Institute, and Michael Brune, a former executive director of the Sierra Club, according to another scheduling document. It was an important moment for the team. The same technology that was being tested on the aircraft carrier's deck would also be deployed in the much larger open-ocean experiment, the research plan shows. "I was impressed with the team that was putting it together," Brune said in an interview. He attended the demo as an adviser to Larson, the crypto entrepreneur who has donated to SilverLining via the Silicon Valley Community Foundation. Brune, who lives in Alameda, said he wasn't aware of the larger experiment until E&E News contacted him. "The engagement with leaders here in Alameda was subpar, and the controversy was pretty predictable," he added. In May 2024, city officials halted the experiment after complaining about the secrecy surrounding it. They also accused the organizers of violating the Hornet's lease, which was only intended to allow museum-related activities. (The Hornet didn't respond to a request for comment.) At a city council meeting the following month, Mayor Ashcraft said she wanted "a deeper understanding of the unintended consequences … not just of this small-scale experiment, but of the science, of this technology [and] where it's leading to." Then she and the other four council members voted unanimously to block the program from resuming its experiment. Between April 2024 and the city council's vote that June, the research team scrambled to limit public backlash against the test. By then, the controversy had attracted national and local media attention. The information request from E&E News sought roughly 14 months of text messages from or to Doherty and Robert Wood, another University of Washington researcher, that included or mentioned their collaborators at SilverLining or SRI. Some of the text messages that were shared by the university did not specify the sender, and Doherty and Wood did not respond to questions about them. In one text message chain on May 15, 2024, one person suggested SilverLining would pay to keep the Hornet museum closed when the tests were running "to give us some breathing space." The sender added, "for risk management and the project [it's] an easy call, and we can cover it." But an unidentified second person responded that "the community could actually find it additionally problematic that the project kept the Hornet shut down." The team members sent each other letters from people who supported the program, including one from science fiction writer Kim Stanley Robinson, whose 2020 novel Ministry of the Future featured a rogue nation that unilaterally implemented planetary-scale solar geoengineering. "The truth is that in the coming decades we are going to have to cope with climate change in many ways involving both technologies and social decisions," he wrote to the city council on May 29, 2024. The Alameda experiment "has the advantage of exploring a mitigation method that is potentially very significant, while also being localized, modular, and reversible. These are qualities that aren't often attributed to geoengineering." After the council vote, SilverLining hired a new public relations firm, Berlin Rosen, to handle the media attention. It also discussed organizing local events to recruit potential allies, emails show. Wanser, SilverLining's executive director, wrote in a June 6, 2024, email to the research team that the program was considering "another run at a proposal to the city post-election, with, hopefully, a build up of local support and education in the interim." Ashcraft, the mayor, said in an email to E&E News that she is "not aware of any additional outreach with the community" by the researchers, adding that they hadn't engaged with her or city staff since the vote. Meanwhile, even before Trump returned to office, the team had begun acknowledging that its mistakes in Alameda had decreased the likelihood of gaining government support for solar geoengineering research. Access to federal aircraft "isn't going to happen any time soon," Doherty, the program director, wrote to Wanser and other team members on June 14, 2024. The studies that the program is pursuing are scientifically sound and would be unlikely to alter weather patterns — even for the Puerto Rico-sized test, said Daniele Visioni, a professor of atmospheric sciences at Cornell University. Nearly 30 percent of the planet is already covered by clouds, he noted. That doesn't mean the team was wise to closely guard its plans, said Visioni, who last year helped author ethical guidelines for solar geoengineering research. "There's a difference between what they should have been required to do and what it would have been smart for them to do, from a transparent perspective, to gain the public's trust," he said. Solve the daily Crossword


CNN
15 hours ago
- CNN
Start your week smart: NASA's future, Starvation in Gaza, Stabbing incident, Extreme heat risk, Swimming showdown
If you've been suffering through the high temperatures that have scorched much of the country this summer, you know the toll it can take on your body, leaving you dizzy, dehydrated and, in some severe cases, at risk of death. But there's another lesser-known impact of extreme heat — and it might surprise you. Here's what else you need to know to start your week smart. 🔦 Few US government agencies have navigated as much turmoil in recent months as NASA. With the impending loss of thousands of jobs looming, this week saw the release of a scathing letter from nearly 300 current and former NASA employees and the abrupt resignation of the director of the Goddard Space Flight Center. Scientists and agency workers criticized budget cuts, grant cancellations and a 'culture of organizational silence.' They also raised concerns about suggested changes to a system of safety checks and balances. President Donald Trump appointed US Secretary of Transportation Sean Duffy as interim NASA administrator to replace Janet Petro, a longtime agency employee. That came after the nomination of tech billionaire Jared Isaacman to lead NASA was rescinded. Some scientists are criticizing the agency as the Trump administration tries to dismantle the NASA Goddard Institute for Space Studies, one of the country's top climate labs. Employees are working remotely after their New York City office was shut down. Back in March, NASA astronauts Suni Williams and Butch Wilmore returned to Earth after gaining international attention as their short trip to space stretched into a saga lasting more than nine months. It's an example of how quickly things can go sideways. Meanwhile, leaks have plagued the International Space Station. 📸 In photos: Astronaut Don Pettit captures unique views of the cosmos. Take a look. Blue Origin took a star-studded all-female crew — including singer Katy Perry and journalist Gayle King — to the 'edge of space' and back. The mission had its critics, but is this the future of spaceflight? Israel says it will open aid corridors as fury grows over starvation in Gaza A 'random' stabbing at a Michigan Walmart left 11 injured, officials say. Here's what we know so far Alabama toddler dies in hot car while in state custody GET '5 THINGS' IN YOUR INBOX If your day doesn't start until you're up to speed on the latest headlines, then let us introduce you to your new favorite morning fix. Sign up here for the '5 Things' newsletter. Looking for a way to beat the summer heat? July 28 is National Water Park Day, so grab your swimsuits and hit the water slide or tube down a lazy river! The International Monetary Fund will release its July 2025 World Economic Outlook Update. This publication provides analyses and projections of the global economy. In an update in April, the IMF said forecasts for global growth had been revised markedly down compared with its January update, reflecting effective tariff rates at levels not seen in a century. The Federal Reserve is set to conclude its fifth interest rate meeting since President Donald Trump returned to office in January, with policymakers expected to hold rates steady once again. The decision is likely to draw sharp criticism from Trump, who has repeatedly clashed with Fed Chair Jerome Powell over the bank's refusal to cut rates. Tension between the two was evident last week during a tour of the Fed's $2.5 billion headquarters renovation, a project the Trump administration has used to intensify pressure on Powell. 📹 Watch this awkward exchange between Powell and the president. The National Transportation Safety Board will begin a three-day public hearing to investigate the January 29 mid-air collision between a regional jet and an Army helicopter over the Potomac River near Washington, DC, that killed 67 people. President Trump's so-called reciprocal tariffs are set to go into effect on August 1 after a 90-day delay, impacting multiple countries, including Mexico, Canada and the European Union. If Trump's proposed duties of 30% do kick in, Americans could wind up paying more for everything from produce to medical equipment, electronics and alcohol. It's also the day we get the monthly jobs report for July. In this episode of the 'One Thing' podcast, CNN's David Rind speaks to science journalist Jane C. Hu about why Republicans are increasingly open to the purported healing properties of psychedelics. Listen here. Prev Next 📸 Check out more images curated by the CNN Photo team. The Tour de France, which began on July 5, wraps up today in Paris. After more than 2,000 miles of racing, riders will make their way down the Champs-Élysées to the finish line. (TK look for a London write) The World Aquatics Championships kick off today in Singapore, and all eyes will be on the high-stakes showdown between swimming legend Katie Ledecky and Canadian phenom Summer McIntosh. Ledecky, 28, boasts nine Olympic golds and 21 world titles, while 18-year-old McIntosh arrives with four Olympic medals and three world records set just last month. 📹 Hear how Ledecky is preparing to face her fiercest challenger yet. And the World Dog Surfing Championships are Saturday at Linda Mar Beach in Pacifica, California. What began as the short-lived TV comedy series 'Police Squad!' in the early 1980s got a second life as 'The Naked Gun' series of movies starring Leslie Nielsen and George Kennedy. Now, more than 30 years after 1994's 'The Naked Gun 33 1/3: The Final Insult,' a reboot starring Liam Neeson and Pamela Anderson arrives on the big screen this Friday. Will it be riddled with moronic jokes, toilet humor and sight gags, just like its predecessors? Let's hope so! 🧠 Take CNN's weekly news quiz to see how much you remember from the week that was! So far, 5.4% of fellow quiz fans have gotten eight or more questions right. How will you fare? Heavy metal icon and reality TV star Ozzy Osbourne passed away last week at the age of 76. Rest in peace, Prince of Darkness. (Click here to view) Today's edition of 5 Things Sunday was edited and produced by CNN's Tricia Escobedo.